Abionyx Pharma SA
PAR:ABNX
Abionyx Pharma SA
PAR:ABNX
Price:
3.255
EUR
-0.76%
Market Closed
Market Cap:
€115.6m
Balance Sheet
Balance Sheet Decomposition
Abionyx Pharma SA
Abionyx Pharma SA
Balance Sheet Decomposition is not available for
Abionyx Pharma SA
Abionyx Pharma SA
Balance Sheet
Abionyx Pharma SA
Abionyx Pharma SA
Currency: EUR
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
11
|
8
|
43
|
25
|
16
|
11
|
1
|
9
|
8
|
4
|
4
|
3
|
|
| Cash |
2
|
1
|
3
|
6
|
0
|
11
|
1
|
9
|
8
|
4
|
4
|
3
|
|
| Cash Equivalents |
9
|
7
|
40
|
19
|
16
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
8
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
4
|
0
|
1
|
2
|
1
|
4
|
3
|
2
|
2
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
4
|
0
|
1
|
2
|
1
|
3
|
2
|
2
|
1
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
2
|
1
|
0
|
0
|
2
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Total Current Assets |
11
|
1
|
0
|
29
|
18
|
13
|
10
|
10
|
13
|
8
|
7
|
6
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
2
|
2
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
5
|
5
|
5
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
5
|
5
|
5
|
|
| Total Assets |
11
N/A
|
0
N/A
|
0
N/A
|
29
N/A
|
18
-37%
|
13
-28%
|
10
-22%
|
10
+0%
|
22
+112%
|
16
-28%
|
15
-6%
|
14
-9%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
4
|
0
|
0
|
5
|
3
|
2
|
1
|
2
|
3
|
2
|
1
|
2
|
|
| Accrued Liabilities |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
5
|
1
|
0
|
1
|
1
|
1
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Total Current Liabilities |
5
|
0
|
1
|
7
|
3
|
9
|
3
|
4
|
7
|
5
|
4
|
4
|
|
| Long-Term Debt |
5
|
0
|
0
|
7
|
6
|
1
|
0
|
0
|
4
|
3
|
3
|
2
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Liabilities |
11
N/A
|
0
N/A
|
0
N/A
|
14
N/A
|
9
-35%
|
9
-1%
|
4
-61%
|
4
+2%
|
11
+205%
|
9
-22%
|
7
-20%
|
6
-13%
|
|
| Equity | |||||||||||||
| Common Stock |
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
|
| Retained Earnings |
117
|
0
|
0
|
153
|
159
|
165
|
163
|
165
|
170
|
3
|
6
|
3
|
|
| Additional Paid In Capital |
117
|
0
|
0
|
167
|
167
|
168
|
169
|
170
|
179
|
9
|
13
|
9
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
0
N/A
|
15
N/A
|
9
-39%
|
4
-57%
|
7
+74%
|
7
-1%
|
11
+61%
|
7
-33%
|
8
+11%
|
8
-5%
|
|
| Total Liabilities & Equity |
11
N/A
|
0
N/A
|
0
N/A
|
29
N/A
|
18
-37%
|
13
-28%
|
10
-22%
|
10
+0%
|
22
+112%
|
16
-28%
|
15
-6%
|
14
-9%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
13
|
0
|
0
|
18
|
18
|
19
|
22
|
24
|
28
|
28
|
32
|
35
|
|
Switch to:
Switch to:
See Also
Discover More
